A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $90.31, with a 24-hour trading volume of $2.26M. The asset's market cap is $280.02B, after moving 0.50% in the last day.
Tokenized AstraZeneca PLC is trading at $90.59, with a tokenized market cap of $679.49K and a 24-hour trading volume of $71.66K. The tokenized asset has moved -0.84% in the past 24 hours.